DocGo's growth story keeps building, analysts say after mixe

DocGo delivered what analysts at Canaccord called “mixed” results, but that was enough for the firm to reiterate its Buy rating and $13 price target.  “At...

Related Keywords

, Remote Monitoring Solutions , Fresenius , Cardiac Remote Monitoring Solutions ,